{"schema_version":"secwatch.filing_event.v1","accession":"0000718937-26-000005","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.544363+00:00","generated_at":"2026-05-15T22:24:09.406549+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"low","headline":"STAAR Surgical appoints interim co-CEOs; reports China stabilization, EVO+ launch, cost cuts","bullets":["Warren Foust and Deborah Andrews named Interim Co-CEOs after Alcon merger rejected by shareholders in Jan 2026.","Cost reductions beat $225M second-half 2025 run rate target; operating expenses lowered significantly.","China EVO ICL demand recovered at mid-single-digit rate in 2025; distributor inventories normalized.","EVO+ received China regulatory approval mid-2025; early demand exceeds expectations; shipments began Nov 2025.","FDA expanded EVO ICL age range to 21-60 in US, adding ~8M potential patients; new SVP hires in supply chain and APAC."],"urls":{"canonical":"https://secwatch.observer/filing/0000718937-26-000005","json":"https://secwatch.observer/filing/0000718937-26-000005.json","markdown":"https://secwatch.observer/filing/0000718937-26-000005.md","text":"https://secwatch.observer/filing/0000718937-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000071893726000005/0000718937-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000071893726000005/staa-20260303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:24:09.406549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}